Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016).

about

Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016).

Item

http://www.wikidata.org/entity/Q38907424

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016).

@en

type

Item

label

Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016).

@en

prefLabel

Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016).

@en

P1476

Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016).

@en

P2093

Li Ma

http://www.w3.org/2001/XMLSchema#string

Lina Yin

http://www.w3.org/2001/XMLSchema#string

P2860

Comorbidities in Cushing's disease

Cushing's syndrome

Stereoisomers of ketoconazole: preparation and biological activity

Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors

Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.

Ketoconazole enantiomer for the treatment of diabetes mellitus.

Mortality in Cushing's syndrome: a systematic review and meta-analysis.

CYP17 inhibitors--abiraterone, C17,20-lyase inhibitors and multi-targeting agents.

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.

P304

1307-1323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543776.2016.1217331

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Qingzhong Hu

P577

2016-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27454103

http://www.w3.org/2001/XMLSchema#string